Evogene Analysis
| Analyst Ratings |
|
Average Target Price
|
4.00
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.18
|
0.00
|
0.18
|
100.00%
|
|
2022-12-31
|
-0.19
|
0.00
|
0.19
|
100.00%
|
|
2022-09-30
|
-0.20
|
-0.16
|
0.04
|
20.00%
|
|
2022-06-30
|
-0.18
|
-0.21
|
-0.03
|
-16.67%
|
|
2022-03-31
|
-0.17
|
-0.20
|
-0.03
|
-17.65%
|
|
2021-12-31
|
-0.20
|
-0.18
|
0.02
|
10.00%
|
|
2021-09-30
|
-0.17
|
-0.19
|
-0.02
|
-11.76%
|
|
2021-06-30
|
-0.18
|
-0.15
|
0.03
|
16.67%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.57
|
|
2021-12-31
|
-0.69
|
|
2020-12-31
|
-0.82
|
|
2019-12-31
|
-0.71
|
|
2018-12-31
|
-0.82
|
|
2017-12-31
|
-0.81
|
|
2016-12-31
|
-0.77
|
|
2015-12-31
|
-0.68
|
|
2014-12-31
|
-0.58
|
|
2013-12-31
|
-0.44
|
|
2012-12-31
|
-0.14
|
|
2011-12-31
|
0.04
|
|
2010-12-31
|
-0.50
|
|
2009-12-31
|
-0.29
|
|
2008-12-31
|
-0.84
|